VANI — VIVANI MEDICAL INC
As of Q2 2026, 8 SEC-registered investment managers reported holding VANI (VIVANI MEDICAL INC) in their latest 13F filings, with a combined reported value of $1.33M across 1.07M shares. That is -28.9% by share count (-436.34K shares) versus the previous quarter, while reported value moved -11.9%. Ownership is concentrated: the five largest holders account for 99.7% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 2 added to existing stakes, 5 trimmed, 5 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
VANI is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 1.55M | $1.91M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 587.75K | $728.91K | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 301.83K | $374.27K | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 116.91K | $144.97K | 0.00% | Add |
| Millennium Management history | Q3 2023 | 93.99K | $95.87K | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 51.11K | $63.37K | 0.00% | Reduce |
| Renaissance Technologies history | Q1 2026 | 37.30K | $37.30K | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q1 2026 | 30.02K | $30.02K | 0.00% | Hold |
| Point72 Asset Management history | Q4 2025 | 18.96K | $23.32K | 0.00% | New |
| Goldman Sachs Group history | Q2 2025 | 14.42K | $18.61K | 0.00% | New |
| Citadel Advisors history | Q1 2026 | 14.10K | $14.10K | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 11.16K | $13.84K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 3.39K | $4.10K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 142 | $176 | 0.00% | Reduce |
| Bank of America Corp history | Q4 2025 | 39 | $48 | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 10 | $12 | 0.00% | Reduce |
| PNC Financial Services history | Q3 2023 | 2 | $2 | 0.00% | New |
| Citigroup Inc history | Q1 2026 | 1 | $1 | 0.00% | Hold |
| Wells Fargo & Co history | Q1 2026 | 1 | $1 | 0.00% | Hold |
New Positions (Q2 2026)
- JPMorgan Chase & Co 3.39K sh · $4.10K
Fully Exited (vs previous quarter)
- Renaissance Technologies sold 37.30K sh · $37.30K
- Charles Schwab Investment Management sold 30.02K sh · $30.02K
- Citadel Advisors sold 14.10K sh · $14.10K
- Citigroup Inc sold 1 sh · $1
- Wells Fargo & Co sold 1 sh · $1
Fund Position History — shares by quarter (top 19 funds)
| Fund | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | 85.44K | 92.50K | 97.05K | 142.55K | 197.14K | 197.14K | 314.93K | 327.88K | 342.89K | 347.15K | 360.53K | 353.90K | 356.25K | 461.65K | 600.58K | 587.75K |
| BlackRock Inc | — | — | — | — | — | — | — | — | 70.97K | 70.69K | 69.70K | 88.41K | 89.11K | 236.06K | 297.50K | 301.83K |
| Northern Trust Corp | 15.55K | 32.98K | 32.98K | 35.19K | 35.19K | 35.19K | 60.42K | 60.38K | 60.38K | 71.92K | 71.92K | 71.92K | 71.92K | 71.92K | 96.46K | 116.91K |
| UBS Group AG | 25 | 3.04K | 5 | 109 | 12.28K | 1.17K | 10.58K | 47.16K | 5 | 18.82K | 7.95K | 11.87K | 7.51K | 6.71K | 337.75K | 51.11K |
| Marshall Wace | — | — | — | — | — | — | — | — | — | — | — | — | — | 141.30K | 92.27K | 11.16K |
| JPMorgan Chase & Co | 19 | 19 | 19 | 19 | 50 | 103 | — | — | — | 71 | 66 | — | — | — | — | 3.39K |
| Fidelity Management & Research (FMR) | — | 162 | 33 | 533 | 33 | — | — | 333 | — | — | — | 79 | 66 | — | 2.32K | 142 |
| Morgan Stanley | 6.62K | 1.95K | 1.95K | 816 | 816 | 816 | 566 | 566 | 418 | 418 | 418 | 426 | 439 | 341 | 341 | 10 |
| Citadel Advisors | 24.34K | 13.25K | — | 10.59K | 10.09K | 18.27K | 83.80K | 47.30K | 25.21K | 33.92K | — | — | 18.37K | 96.21K | 14.10K | — |
| Point72 Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | — | 18.96K | — | — |
| Renaissance Technologies | — | 56.60K | — | — | — | 15.70K | 12.14K | — | — | — | — | — | 44.86K | 97.98K | 37.30K | — |
| Bank of America Corp | — | 39 | 666 | 666 | — | 36 | — | 254 | 320 | 270 | 284 | 321 | 43 | 39 | — | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | 1 | 1 | — |
| Charles Schwab Investment Management | — | — | — | 30.02K | 30.02K | 30.02K | 30.02K | 30.02K | 30.02K | 30.02K | 30.02K | 30.02K | 30.02K | 30.02K | 30.02K | — |
| Vanguard Group | 299.12K | 299.33K | 402.09K | 411.96K | 450.44K | 452.10K | 850.12K | 900.33K | 967.40K | 967.40K | 967.40K | 1.43M | 1.34M | 1.55M | — | — |
| Wells Fargo & Co | 395 | 578 | 249 | 260 | 208 | 219 | 223 | — | — | — | — | 1 | 1 | 1 | 1 | — |
| Goldman Sachs Group | 21.27K | — | — | — | — | — | — | — | — | — | — | 14.42K | — | — | — | — |
| Millennium Management | 19.90K | 138.33K | 115.77K | 99.28K | 93.99K | — | — | — | — | — | — | — | — | — | — | — |
| PNC Financial Services | — | — | — | — | 2 | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details